Labcorp’s pathologists will use the software to review, interpret and manage digital images of slides for primary diagnosis.

The Dexcom CEO will lead the lobbying group’s sector representing diabetes tech companies around the world.

Medtronic on Tuesday priced a planned initial public offering for its MiniMed diabetes spinoff at up to $784 million. MiniMed ...

The bloc said it needed “full clarity” on the United States’ tariff plans after a Supreme Court ruling last week struck down ...

Masimo’s board considered other potential partners before determining Danaher was an “ideal fit,” executives at the patient ...

The absence of an alert provides limited reassurance, particularly for older adults or people with an elevated risk of high ...

Called Stealth AXiS, the surgical system builds on Medtronic’s Mazor robotic platform, as the medical device maker takes ...

CEO Scott Whitaker said the medtech lobbying group stands ready to work with President Donald Trump to address trade ...

The Food and Drug Administration warning letter detailed unreported hypoglycemic episodes and a software change to correct ...

After medical device M&A picked up last year, 2026 is off to a busy start. Boston Scientific’s planned $14.5 billion ...

CEO Geoff Martha said that while Hugo may not “move the needle” for Medtronic’s surgical business yet, the system is growing ...

As Medtronic prepares to spin out its diabetes business, a spokesperson said the company is considering the structure, capabilities and scale needed to succeed.